X-57286935-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_174912.4(FAAH2):c.110C>T(p.Ala37Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,203,736 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_174912.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAAH2 | NM_174912.4 | c.110C>T | p.Ala37Val | missense_variant | 1/11 | ENST00000374900.5 | NP_777572.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAAH2 | ENST00000374900.5 | c.110C>T | p.Ala37Val | missense_variant | 1/11 | 1 | NM_174912.4 | ENSP00000364035.4 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 8AN: 110513Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32715
GnomAD3 exomes AF: 0.0000285 AC: 5AN: 175696Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 60594
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1093174Hom.: 0 Cov.: 31 AF XY: 0.00000836 AC XY: 3AN XY: 359044
GnomAD4 genome AF: 0.0000724 AC: 8AN: 110562Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32774
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 23, 2024 | The c.110C>T (p.A37V) alteration is located in exon 1 (coding exon 1) of the FAAH2 gene. This alteration results from a C to T substitution at nucleotide position 110, causing the alanine (A) at amino acid position 37 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at